Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine + Amodiaquine in Uncomplicated Falciparum Malaria
NCT03355664Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of amodiaquine in Malaria, sponsored by University of Oxford. Started Mar 2018; status: completed.
02
Drugs
amodiaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT03355664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03355664.